These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2464195)

  • 1. The development of a bivalent vaccine against diarrhoeal disease.
    Forrest BD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):449-57. PubMed ID: 2464195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
    Forrest BD; LaBrooy JT
    Vaccine; 1991 Jul; 9(7):515-20. PubMed ID: 1716810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future vaccines against enteric pathogens.
    Levine MM; Edelman R
    Infect Dis Clin North Am; 1990 Mar; 4(1):105-21. PubMed ID: 2155260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
    Chen D; Ma Q
    Chin J Biotechnol; 1997; 13(1):43-50. PubMed ID: 9376506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
    J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities.
    Viret JF; Favre D
    Biologicals; 1994 Dec; 22(4):361-72. PubMed ID: 7540016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay.
    Chau PY; Tsang RS; Lam SK; La Brooy JT; Rowley D
    Clin Exp Immunol; 1981 Dec; 46(3):515-20. PubMed ID: 7337978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
    Levine MM; Tacket CO; Herrington D; Losonsky G; Murphy J; Ferreccio C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):459-69. PubMed ID: 3064323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of live bacterial vaccines.
    Lindberg AA
    Dev Biol Stand; 1995; 84():211-9. PubMed ID: 7796956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors of Salmonella typhi virulence in relation to the development of new vaccines].
    García JA; Paniagua J; Pelayo R; Isibasi A; Kumate J
    Salud Publica Mex; 1992; 34(3):262-7. PubMed ID: 1615345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral typhoid vaccine. Acambis/Berna.
    Witherell GW
    Curr Opin Investig Drugs; 2003 Aug; 4(8):1010-8. PubMed ID: 14508886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210.
    Attridge SR; Daniels D; Morona JK; Morona R
    Microb Pathog; 1990 Mar; 8(3):177-88. PubMed ID: 1696342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.